- Home
- XRTX vs CNEY Comparison
XRTX vs CNEY Comparison
Compare XRTX & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRTX | CNEY |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | Canada | China |
| Employees | 3 | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 3.4M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XRTX | CNEY |
|---|---|---|
| Price | $3.02 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 458.1K |
| Earning Date | 05-15-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.12 |
| 52 Week High | $3.60 | $3.25 |
Technical Indicators
Market Signals| Indicator | XRTX | CNEY |
|---|---|---|
| Relative Strength Index (RSI) | 74.24 | 55.67 |
| Support Level | $0.52 | $0.54 |
| Resistance Level | N/A | $0.80 |
| Average True Range (ATR) | 0.37 | 0.12 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 64.78 | 53.21 |
Price Performance
Historical ComparisonAbout XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.